Not exact matches
In fact, when the 2007 paper came out, the commentaries in most scientific publications were quick to point out that, despite the success with adult
cells, there was
still a need to continue embryo - destructive research and that it would be critical to the advancement of science that research on
embryonic stem cells continue.
Although primed, post-implantation
embryonic stem cells can
still turn into any type of human
cell, they are more difficult to work with than the pre-implantation, naive
cells.
«
Still,
embryonic stem cells are a potent tool in the armamentarium against disease.
Importantly, researchers must
still study existing
embryonic stem cell lines — the gold standard — to rule out any hidden risks in the lab - made
cells, he says.
«Genetically, this type of clone is
still a member of our species,» says David Prentice, a cellular biologist at Indiana State University and cofounder of Do No Harm, a group of scientists favoring alternatives to
embryonic stem cell research.
Amid all this, are you
still trying to achieve your first dream, harvesting
embryonic stem cells from human clones?
You can do all kinds of tricks with
embryonic stem cells, but if they come from another individual, you
still have the problem of rejection.
Still, the genetic homogeneity of largely inbred mouse strains may be misleading when it comes to understanding human
stem cells, cautions Peter Andrews, professor of biomedical science and co-director of the Centre for Stem Cell Biology at the University of Sheffield, U.K. «In the human, every embryonic stem cell that we're working with that comes from a different person is genetically different,» says Andr
stem cells, cautions Peter Andrews, professor of biomedical science and co-director of the Centre for
Stem Cell Biology at the University of Sheffield, U.K. «In the human, every embryonic stem cell that we're working with that comes from a different person is genetically different,» says Andr
Stem Cell Biology at the University of Sheffield, U.K. «In the human, every embryonic stem cell that we're working with that comes from a different person is genetically different,» says Andr
Cell Biology at the University of Sheffield, U.K. «In the human, every
embryonic stem cell that we're working with that comes from a different person is genetically different,» says Andr
stem cell that we're working with that comes from a different person is genetically different,» says Andr
cell that we're working with that comes from a different person is genetically different,» says Andrews.
In the case of
embryonic stem cell research, embryos themselves were protected — not as fully as they would have been had all embryo - destructive research been forbidden, of course, but
still not insignificantly.
This opinion is echoed by Stephen Dunn, director of research at Boca Raton, Fla., securities firm Dawson James: «The
embryonic stem cell scene
still is in that science phase.»
While it is widely accepted that
embryonic stem cells (ESCs) have the ability to become any type of
cell, the molecular causes for this characteristic are
still under much investigation, although one suspected player is chromatin.
While
embryonic stem cells are widely studied, a lesser known, but
still significant, population of
stem cells also resides within the early developing embryo: trophoblast
stem cells (TSCs).
These
cells, known as induced pluripotent
stem cells, hold promise, but scientists would
still like the opportunity to pursue work with the
embryonic stem cells.
Despite the promise of iPS
cells, scientists are
still struggling to understand whether their developmental potential is equivalent to that of
embryonic stem cells.
However, it is
still unclear how similar human iPSCs are to human
Embryonic Stem Cells (hESCs).